Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is a recognized leader in cancer treatment, research, prevention, education and community outreach. We are among a select group to have received the National Cancer Institute’s highest rating of Exceptional – each of the last two times we underwent review.
Honored and more driven than ever, we are forward-focused in the fight against cancer, breaking the boundaries of research, clinical trials and prevention. When it’s time to partner in patient care, put your trust in Washington University Physicians at Siteman Cancer Center.
Siteman offers more than 600 clinical studies and enrollment of more than 12,000 patients in clinical studies per year.
View TrialsWashington University physician scientists are developing leading-edge therapies to treat blood and bone marrow cancers.
Learn MoreWe're building community relationships, providing clinical services, and conducting health disparities research throughout the region.
Learn More
Program researchers are defining the fundamental mechanisms that regulate breast cancer pathology, to develop personalized strategies for the prevention, diagnosis and treatment of all stages and subtypes of breast cancer.
Program goals are to identify basic mechanisms regulating normal and malignant hematopoiesis and to develop innovative strategies to prevent, stratify and treat hematopoietic malignancies.
Program goals are to identify and map the complex cellular mechanisms that drive cancer development, progression and metastasis.
Program researchers are developing novel imaging agents and innovative methods for radionuclide, MR, ultrasound optical and hybrid imaging technologies, including photoacoustic imaging and theranostics.
Washington University researchers at Siteman Cancer Center are advancing cancer care and prevention, from radiological techniques in the diagnosis of disease to therapies based on our expertise in stem cell biology and beyond.
Program researchers are focused on discovering somatic and germline genomic alterations that are either shared or unique across various solid tumor malignancies, and translating these discoveries into novel therapeutics that will improve quality of life and survival for cancer patients.
For more than 30 years, the immunology community at Washington University School of Medicine in St. Louis has had a strong reputation for the significant breadth and depth of its contributions to the field of immunology and its highly interactive and collaborative nature.
For information about referring patients to Siteman, click on the links below or call 800-600-3606.
